# Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil

> **NCT02043652** · NA · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 119 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Chloroquine
- **DRUG:** Primaquine

## Key facts

- **NCT ID:** NCT02043652
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2018-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02043652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02043652, "Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02043652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*